These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Impact of the type of dialyser on the clinical outcome in chronic haemodialysis patients: does it really matter? Grooteman MP; Nubé MJ Nephrol Dial Transplant; 2004 Dec; 19(12):2965-70. PubMed ID: 15507481 [No Abstract] [Full Text] [Related]
7. What clinically important advances in understanding and improving dialyzer function have occurred recently? Ward RA; Leypoldt JK; Clark WR; Ronco C; Mishkin GJ; Paganini EP Semin Dial; 2001; 14(3):160-74. PubMed ID: 11422918 [No Abstract] [Full Text] [Related]
10. Biocompatibility and the clinical choice of dialysis membranes. Mujais SK; Ivanovich P; Bereza LA; Vidovich M Contrib Nephrol; 1995; 113():101-9. PubMed ID: 7712716 [No Abstract] [Full Text] [Related]
11. Mid-dilution on-line haemodiafiltration in a standard dialyser configuration. Krieter DH; Collins G; Summerton J; Spence E; Moragues HL; Canaud B Nephrol Dial Transplant; 2005 Jan; 20(1):155-60. PubMed ID: 15522903 [TBL] [Abstract][Full Text] [Related]
12. Comment on middle molecule removal in low-flux polysulfone dialyzers: impact of flows and surface area on whole-body and dialyzer clearances. Polaschegg HD Hemodial Int; 2006 Apr; 10(2):215-6; author reply 216. PubMed ID: 16623678 [No Abstract] [Full Text] [Related]
13. Myeloperoxidase serves as a marker of oxidative stress during single haemodialysis session using two different biocompatible dialysis membranes. Krieter DH; Lemke HD; Wanner C Nephrol Dial Transplant; 2006 Feb; 21(2):546; author reply 546. PubMed ID: 16249195 [No Abstract] [Full Text] [Related]
14. Using AN69 ST membrane: a dialysis centre experience. Maheut H; Lacour F Nephrol Dial Transplant; 2001 Jul; 16(7):1519-20. PubMed ID: 11427664 [No Abstract] [Full Text] [Related]
15. Are biocompatible membranes superior for hemodialysis therapy? van Ypersele de Strihou C Kidney Int Suppl; 1997 Nov; 62():S101-4. PubMed ID: 9350694 [No Abstract] [Full Text] [Related]
16. Clinical manifestations of AB-amyloidosis: effects of biocompatibility and flux. Schiffl H; Fischer R; Lang SM; Mangel E Nephrol Dial Transplant; 2000 Jun; 15(6):840-5. PubMed ID: 10831638 [TBL] [Abstract][Full Text] [Related]
17. Does an alteration of dialyzer design and geometry affect biocompatibility parameters? Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675 [TBL] [Abstract][Full Text] [Related]
18. The practical application of ozone in dialysis. Amato RL; Curtis J Nephrol News Issues; 2002 Sep; 16(10):27-30. PubMed ID: 12271927 [No Abstract] [Full Text] [Related]
19. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane. Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457 [TBL] [Abstract][Full Text] [Related]
20. Vancomycin clearance with high-flux dialysis membranes. Anandan JV; Touchette MA Int J Artif Organs; 1998 Mar; 21(3):131-3. PubMed ID: 9622110 [No Abstract] [Full Text] [Related] [Next] [New Search]